Last $0.11 USD
Change Today -0.0002 / -0.18%
Volume 1.0K
ACUS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

acusphere inc (ACUS) Snapshot

Open
$0.11
Previous Close
$0.11
Day High
$0.11
Day Low
$0.11
52 Week High
01/22/14 - $1.11
52 Week Low
09/3/14 - $0.10
Market Cap
549.5K
Average Volume 10 Days
3.5K
EPS TTM
$-12.60
Shares Outstanding
5.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACUSPHERE INC (ACUS)

Related News

No related news articles were found.

acusphere inc (ACUS) Related Businessweek News

No Related Businessweek News Found

acusphere inc (ACUS) Details

Acusphere, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of Imagify (perflubutane polymer microspheres) for injectible suspension. The company’s Imagify acts as a cardiovascular drug for the detection of coronary artery disease by enabling ultrasound to accurately assess myocardial perfusion. It serves customers in the United States, Europe, and Asia. Acusphere, Inc. was founded in 1993 and is headquartered in Lexington, Massachusetts.

acusphere inc (ACUS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

acusphere inc (ACUS) Key Developments

Acusphere, Inc. Presents at Boston CEO Conference, Jun-04-2014 04:00 PM

Acusphere, Inc. Presents at Boston CEO Conference, Jun-04-2014 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Mark W. Leuchtenberger, Chief Executive Officer, President and Director.

Acusphere Appoints William Ramage as Chief Development Officer

Acusphere, Inc. announced that William I. Ramage, D. Phil., has been appointed Chief Development Officer. Dr. Ramage brings with him over 30 years of imaging experience, 25 of which have been dedicated to cardiovascular imaging. He served as an Executive Consultant at Acusphere from March 2000 to October 2013 where he was responsible for key clinical and regulatory activities and as an Independent Business Development and Strategic Marketing Consultant from August 1999 until March 2000.

Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD

Effective October 21, 2013, Acusphere, Inc. changed its Pink Sheets LLC stock ticker symbol to ACUS from ACUSD.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACUS:US $0.11 USD -0.0002

ACUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celgene Corp $94.97 USD +2.97
View Industry Companies
 

Industry Analysis

ACUS

Industry Average

Valuation ACUS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACUSPHERE INC, please visit www.acusphere.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.